Teva Pharmaceutical Industries Ltd (ADR) (TEVA)
$52.03
0.57 (+1.10%)
| CAPS Rating |
|
|---|---|
| Open | $51.60 |
| Previous Close | $51.46 |
| Daily Range | $51.21 - $52.22 |
| 52-Week Range | $39.75 - $54.95 |
| Market Cap | $47.45B |
| P/E Ratio | 52.67 |
| Dividend (Yield) | 0.48 (0.90%) |
| Volume | 3,759,726 |
| Average Daily Volume | 4,665,000 |
TEVA
VS S&P 500 (SPY)
How do you think TEVA will perform vs the S&P 500?
Caps
Motley Fool CAPS is a community working together to find better stocks and to become better investors.
TEVA Advanced Details
- CAPS Community Analysis: Commentary, Scorecard
- Advanced Financial Analysis: Historical Prices, Chart, Stats, Ratios, Earnings/Growth Rates, Statements, SEC Filings
TEVA News and Commentary
- XNPT is on the move – Blog at The Motley Fool
- MFI Stock Review: Cephalon (CEPH) – Blog at The Motley Fool
- CNBC on Teva Pharmaceutical Industries Limited – Ockham-RazorWire
- CNBC on Teva Pharmaceutical Industries Limited – Ockham-RazorWire
- Nice Quarter, Teva. What Will You Buy Next? – The Motley Fool
- 10 Stocks Shaking the Market – The Motley Fool
- BRIEF-Teva Pharmaceutical 2009, 2010 EPS outlook – Reuters
- UPDATE 1-Teva Q3 profit higher as Copaxone sales jump – Reuters
- Finally Convinced? Benlysta Works! – The Motley Fool
- Winners and Losers of the House Health-Care Reform Bill – The Motley Fool
- Shrugging Off the Side Effects – The Motley Fool
- Earnings? Yawn. Trial Data? Moving! – The Motley Fool
- It's Not As Frightening As It First Appears – The Motley Fool
- For Tysabri, 23 Is 10 Too Many – The Motley Fool
- 5-Star Stocks Poised to Pop: Teva – The Motley Fool
- All Tysabri, All the Time – The Motley Fool
- America's Next Top Growth Stock – The Motley Fool
- Little Discord on Acorda Drug – The Motley Fool
- A Big Upgrade for Teva Pharmaceutical – The Motley Fool
- The Best Investments in the World – The Motley Fool
RSS Headlines
Fool UK
